CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Verve Therapeutics Inc. (VERV) on Thursday reported a loss of $41.1 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 67 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.
The biotechnology firm posted revenue of $1 million in the period.
For the year, the company reported a loss of $157.4 million, or $2.91 per share. Revenue was reported as $1.9 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VERV at https://www.zacks.com/ap/VERV
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
